Anxiety and regional cortical glucose metabolism in patients with Alzheimers disease
Neurochem Res 37:27062714 Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P, Alzheimer's Disease Cooperative S (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures
The Journal of Clinical Hypertension, 8 (8), 596599
The electrophilic nature of SFN drives its direct conjugation with glutathione, effectively depleting intracellular GSH pools and consequently inhibiting glutathione peroxidase 4 (GPX4) activity